Can Quantitative Ultrasound be Used for the Evaluation of Bone Health in Adolescents and Adults With Cystic Fibrosis

This study is currently recruiting participants.

Verified by University Hospital, Ghent, April 2009

First Received: September 12, 2005 Last Updated: April 7, 2009 History of Changes

Sponsored by:	University Hospital, Ghent
Information provided by:	University Hospital, Ghent
ClinicalTrials.gov Identifier:	NCT00221572

Purpose

Measurement of bone density of Cystic Fibrosis patients with two techniques and correlation to serum bone parameters, use of steroids, lung function and nutritional status.

Condition	Intervention
Cystic Fibrosis	Procedure: Determination of bot density of Cystic Fibrosis patients

Genetics Home Reference related topics: cystic fibrosis

MedlinePlus related topics: Cystic Fibrosis Ultrasound

U.S. FDA Resources

Study Type:	Observational
Study Design:	Prospective
Official Title:	Can Quantitative Ultrasound be Used for the Evaluation of Bone Health in Adolescents and Adults With Cystic Fibrosis

Further study details as provided by University Hospital, Ghent:

Estimated Enrollment:	100
Study Start Date:	July 2005
Estimated Study Completion Date:	December 2009
Estimated Primary Completion Date:	December 2009 (Final data collection date for primary outcome measure)

Detailed Description:

Measurement of bone density of Cystic Fibrosis patients with two techniques and correlation to serum bone parameters, use of steroids, lung function and nutritional status.

Eligibility

Ages Eligible for Study:	12 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria: - Patients with Cystic Fibrosis Exclusion Criteria: -

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00221572

Contacts

Contact: Eddy Robberecht, MD, PhD

+ 32 9 332.35.89

eddy.robberecht@UGent.be

Locations

Belgium
University Hospital Ghent	Recruiting
Ghent, Belgium, 9000
Contact: Stephanie Van Biervliet, MD + 32 9 332.55.14 stephanie.vanbiervliet@UGent.be

Sponsors and Collaborators

University Hospital, Ghent

Investigators

Principal Investigator:

Stephanie Van Biervliet, MD

University Hospital, Ghent

More Information

Additional Information:

Website University Hospital Ghent This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party:	University Hospital Ghent ( Eddy Robberecht )
Study ID Numbers:	2005/149
Study First Received:	September 12, 2005
Last Updated:	April 7, 2009
ClinicalTrials.gov Identifier:	NCT00221572 History of Changes
Health Authority:	Belgium: Institutional Review Board

Study placed in the following topic categories:

Digestive System Diseases
Genetic Diseases, Inborn
Respiratory Tract Diseases
Cystic Fibrosis

Fibrosis
Lung Diseases
Infant, Newborn, Diseases
Pancreatic Diseases

Additional relevant MeSH terms:

Pathologic Processes
Digestive System Diseases
Genetic Diseases, Inborn
Respiratory Tract Diseases
Cystic Fibrosis

Fibrosis
Lung Diseases
Infant, Newborn, Diseases
Pancreatic Diseases

ClinicalTrials.gov processed this record on May 06, 2009